ORGO earnings call for the period ending September 30, 2024. Organogenesis ( ORGO -1.43%) Q3 2024 Earnings Call Nov 12, 2024, ...

Organogenesis Holdings Inc. has secured a $130 million private placement deal with Avista Healthcare Partners to bolster its strategic growth, repay debt, and repurchase shares. This investment, ...

Organogenesis Holdings ( (ORGO) ) has released its Q3 earnings. Here is a breakdown of the information Organogenesis Holdings presented to its ...

CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Tuesday reported profit of $12.3 million in its third quarter. The Canton, Massachusetts-based company said it had net ...

Organogenesis (NASDAQ:ORGO – Get Free Report) will release its earnings data after the market closes on Tuesday, November ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of ...

Organogenesis (ORGO) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.02 per share a year ago.

Organogenesis is the process by which the internal organs and specific structures such as the limb are formed during development of an organism. Organogenesis involves the coordination of multiple ...

On Wednesday, Organogenesis Holdings Inc (ORGO) stock saw a modest uptick, ending the day at $4.43 which represents a slight increase of $0.98 or 28.41% from the prior close of $3.45. The stock opened ...

This private placement offering represents a significant move by Organogenesis Holdings Inc. to secure strategic growth ...